Financials

  • Market Capitalization 2.43 B
  • Employee 398
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
112.53
Price to sales ratio
6.8

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1836
TARS
Tarsus Pharmaceuticals, Inc. - Common Stock
59.31 USD+2.01%-13.26%-4.46%-10.22%2.55 B USD
1845
BCRX
BioCryst Pharmaceuticals, Inc. - Common Stock
9.91 USD-5.17%-4.16%+13.13%+10.11%2.52 B USD
1872
AGIO
Agios Pharmaceuticals, Inc. - Common Stock
40.55 USD-1.65%+2.35%+36.58%-6.55%2.41 B USD
1885
NRIX
Nurix Therapeutics, Inc. - Common stock
22.71 USD-1.52%-5.65%+32.81%+102.59%2.36 B USD

Frequently asked questions about Vericel Corporation - Common Stock

What is the Vericel Corporation - Common Stock stock price today?

The current price of Vericel Corporation - Common Stock (VCEL) is 47.49. Over the past 24 hours, the stock has changed by +1.04%. Follow the VCEL chart for real-time price dynamics.

What is the stock ticker of Vericel Corporation - Common Stock?

Vericel Corporation - Common Stock trades under the ticker VCEL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Vericel Corporation - Common Stock stock going up?

VCEL has changed by +0.87% over the last week, +25.40% over the last month, and +30.65% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Vericel Corporation - Common Stock net income for the last quarter?

Vericel Corporation - Common Stock reported net income of -6.3 M for the last quarter. The previous quarter showed 23.24 M, which means net income changed by -127.11%.

How many employees does Vericel Corporation - Common Stock have?

As of the latest available data, Vericel Corporation - Common Stock has 398 employees. Workforce size can provide additional context about the company's scale and operations.

What is Vericel Corporation - Common Stock EBITDA?

Vericel Corporation - Common Stock EBITDA is -4.8 M, and its EBITDA margin is -7.01%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Vericel Corporation - Common Stock stock?

You can buy Vericel Corporation - Common Stock (VCEL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Vericel Corporation - Common Stock stock?

Investing in Vericel Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VCEL chart and related analysis on metatrader.com as part of your research.

Vericel Corporation - Common Stock

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

News